Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

doranidazole

Known as: (2RSs,3SR)-3-((2-nitroimidazol-1-yl)methoxy)butane-1,2,4-triol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BackgroundGlioblastoma is one of the intractable cancers and is highly resistant to ionizing radiation. This radioresistance is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Novel hypoxic cell radiosensitiser doranidazole was tested for unresectable pancreatic cancer administered at intraoperative… Expand
  • figure 1
  • table 1
Is this relevant?
2008
2008
OBJECTIVE This study was designed to assess the potential of the nitroaromatic radiosensitizer doranidazole to preferentially… Expand
Is this relevant?
2007
2007
PURPOSE This Phase I/II trial was conducted to assess the efficacy and safety of PR-350, a novel hypoxic cell radiosensitizer… Expand
Is this relevant?
2005
2005
We have investigated the radiosensitizing effect of doranidazole, a hypoxic cells radiosensitizer, using SCCVII tumor cells of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2002
2002
We investigated the sensitizing effect of the 2-nitroimidazole analogue doranidazole, a new hypoxic radiosensitizer, on radiation… Expand
  • figure 2
  • figure 1
Is this relevant?
2002
2002
This study was performed to confirm the radiation-chemical properties of the 2-nitroimidazole derivative doranidazole, (+/-)-(2RS… Expand
Is this relevant?
2001
2001
A phase Ia study of a 2-nitroimidazole nucleoside analog radiosensitizer doranidazole was conducted to evaluate its toxicity and… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2000
2000
BACKGROUND AND PURPOSE A clinical study of the new 2-nitroimidazole nucleoside analogue doranidazole (PR-350) in combination with… Expand
Is this relevant?
2000
2000
A new 2-nitroimidazole radiosensitizer doranidazole is now undergoing clinical evaluation in combination with intraoperative… Expand
Is this relevant?